Cytokine release syndrome in severe COVID-19
Copyright policy )Cytokine release syndrome in severe COVID-19
Lessons from arthritis and cell therapy in cancer patients point to therapy for severe disease
- University of Pennsylvania United States
- Walter Reed National Military Medical Center United States
Respiratory Distress Syndrome, Receptors, Chimeric Antigen, Multidisciplinary, Interleukin-6, SARS-CoV-2, Pneumonia, Viral, COVID-19, Antibodies, Monoclonal, Humanized, Severe Acute Respiratory Syndrome, Immunotherapy, Adoptive, Lymphohistiocytosis, Hemophagocytic, Betacoronavirus, C-Reactive Protein, Interleukin-6 Inhibitors, Humans, Coronavirus Infections, Cytokine Release Syndrome, Pandemics
Respiratory Distress Syndrome, Receptors, Chimeric Antigen, Multidisciplinary, Interleukin-6, SARS-CoV-2, Pneumonia, Viral, COVID-19, Antibodies, Monoclonal, Humanized, Severe Acute Respiratory Syndrome, Immunotherapy, Adoptive, Lymphohistiocytosis, Hemophagocytic, Betacoronavirus, C-Reactive Protein, Interleukin-6 Inhibitors, Humans, Coronavirus Infections, Cytokine Release Syndrome, Pandemics
selected citations These citations are derived from selected sources.This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).2K popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Top 0.01% influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Top 0.1% impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Top 0.01%
Citations provided by BIP!Popularity provided by BIP!